In hepatocellular carcinoma (HCC) and glioblastoma multiforme (GBM), abnormal expression of BMAL1 is significantly correlated with enhanced tumor cell proliferation capacity, increased invasive potential, and heightened migratory activity [17]. The gene discussed is BMAL1; the disease is glioblastoma.